Sandbox:Sogand: Difference between revisions

Jump to navigation Jump to search
Line 323: Line 323:
{{familytree | | | | | | | |,|-|-|-|^|-|-|.| | | | | | | | | | |!| | | | | | | | | |!| | | |}}
{{familytree | | | | | | | |,|-|-|-|^|-|-|.| | | | | | | | | | |!| | | | | | | | | |!| | | |}}
{{familytree | | | | | | | | E01 | | | E02 | | | | | | | | | | E03 | | | | | | | | E04 | | |E01=Evidence of abnormality,comparison of mobility with that of known abnormalities, if HBS suspected: solubility test |E02=Separation/quantification |E03=Evalution of all data and findings |E04=Evalution of all data and findings | | |}}
{{familytree | | | | | | | | E01 | | | E02 | | | | | | | | | | E03 | | | | | | | | E04 | | |E01=Evidence of abnormality,comparison of mobility with that of known abnormalities, if HBS suspected: solubility test |E02=Separation/quantification |E03=Evalution of all data and findings |E04=Evalution of all data and findings | | |}}
{{familytree | | | | | | | | |!| | | | |!| | | | | | | | | | | |!| | | | | | | | | |!| | }}
{{familytree | | | | | | | | |`|-|v|-|-|'| | | | | | | | | | | |!| | | | | | | | | |!| | }}
{{familytree | | | | | | | | | | |!| | | | | | | | | | | | | | F01 | | | | | | | | F02 | | |F01=Diagnisis of β-thalassemia |F02=Dignisis of α-thalassemia | | |}}
{{familytree | | | | | | | | | | |!| | | | | | | | | | | | | | |!| | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | G01 | | | | | | | | | | | | | G02 | | |G01=DNA sequencing if needed |G02=DNA sequencing if needed(thalassemia major, thalassemia intermedia | | |}}
{{familytree | | | | | | | | | | |!| | | }}
{{familytree | | | | | | | | | | H01 | | |H01=Evaluation of all data and findings(including blood count ethnic and origin | | |}}
{{familytree | | | | | | | | | | |!| | | | }}
{{familytree | | | | | | | | | | I01 | | |I01=Diagnosis of hemoglobinopathy | | |}}


== References ==
== References ==

Revision as of 17:54, 7 September 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]

On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from disseminated intravascular coagulation (DIC) , thrombotic thrombocytopenic purpura (TTP),systemic vasculitis , [disease 4], [disease 5], and [disease 6].

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Occur Histopathology
Diarrhea Abdominal pain decrease urin Physical exam 1 Physical exam 2 fd CBC PC PT PTT FDP D-dimer LDH haptoglobin Coombs test PBS BUN Cr S/C Pediatric Adult Imaging 3
Disseminated intravascular coagulation (DIC) NL/_
Hemolytic uremic syndrome Hemolitic anemia NL NL NL +++ +
Thrombotic thrombocytopenic purpura (TTP) + +++
Systemic vasculitis
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 D Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Differential Diagnosis 4
Differential Diagnosis 5
Differential Diagnosis 6

References

Template:WH Template:WS


Pathophysiology

  1. The pathophysiolgy of xxx disease in unknown.
  2. But it may follow xxx pathway
    • It is believed that xxx might work on yyy to produce zz.

Pathology

  • Idiopathic
  • Itarogenic
  • cardiac

References

 
 
 
 
 
 
 
 
 
 
 
 
 
 
History & clinical symptoms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blood test
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
hemolysate
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnosis of abnormal hemoglobins
 
 
 
 
 
 
 
 
 
 
 
Diagnisis of β-thalassemia
 
 
 
 
 
 
 
Dignisis of α-thalassemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alkaline electrophoresis
• acid electrophoresis
•HPLC
 
 
 
 
 
 
 
 
 
 
 
Electrophoresis HPLC
• HbA2,Hbf
 
 
 
 
 
 
 
Electrophoresis HPLC
• DNA testing
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evidence of abnormality,comparison of mobility with that of known abnormalities, if HBS suspected: solubility test
 
 
Separation/quantification
 
 
 
 
 
 
 
 
 
Evalution of all data and findings
 
 
 
 
 
 
 
Evalution of all data and findings
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnisis of β-thalassemia
 
 
 
 
 
 
 
Dignisis of α-thalassemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNA sequencing if needed
 
 
 
 
 
 
 
 
 
 
 
 
DNA sequencing if needed(thalassemia major, thalassemia intermedia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluation of all data and findings(including blood count ethnic and origin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnosis of hemoglobinopathy